Phase I–II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (9) , 1242-1248
- https://doi.org/10.1016/0959-8049(93)90065-n
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical pharmacokinetics of mitoxantrone after intraperitoneal administrationCancer Chemotherapy and Pharmacology, 1992
- Escalating dose regimen of intraperitoneal mitoxantrone: Phase I study—clinical and pharmacokinetic evaluationEuropean Journal of Cancer and Clinical Oncology, 1988
- Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavityCancer Treatment Reviews, 1986
- AnnouncementGynecologic Oncology, 1986
- Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Pharmacology of mitoxantrone: mode of action and pharmacokineticsInvestigational New Drugs, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Pharmacology of Intraperitoneal ChemotherapyCancer Investigation, 1983
- Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantroneJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Reporting results of cancer treatmentCancer, 1981